HER2

From WikiMD's WELLNESSPEDIA

(Redirected from HER2 positive)

HER2 or Human Epidermal growth factor Receptor 2 is a protein that in humans is encoded by the ERBB2 gene. HER2 is a member of the human epidermal growth factor receptor (HER/EGFR/ERBB) family. Amplification or over-expression of this gene has been shown to play an important role in the development and progression of certain aggressive types of breast cancer.

Function[edit]

In normal cells, HER2 controls aspects of cell growth and division. However, when the HER2 gene is mutated, cells can grow and divide in an uncontrolled way, leading to the development of cancer.

Role in Cancer[edit]

HER2 is found in excessive amounts on the surface of some cancer cells, including some types of breast cancer, ovarian cancer, stomach cancer, and other solid tumors. These cancers are often referred to as "HER2-positive" and they tend to be more aggressive than other types of cancer.

HER2 Testing[edit]

HER2 testing is used to determine if a breast cancer is HER2-positive. This is important because HER2-positive breast cancers can be treated with drugs that specifically target the HER2 protein, such as trastuzumab and pertuzumab.

Treatment[edit]

HER2-positive cancers are typically treated with a combination of surgery, radiation therapy, and chemotherapy. In addition, targeted therapies that specifically attack the HER2 protein, such as trastuzumab and pertuzumab, are often used.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.